Weight Loss

Page 2 of 6

Doctor listening with a stethoscope to the heart of an overweight Asian woman
Life

Patients call out fat-shaming doctors for hurting their health: ‘I always go in with my guard up’

By
February 11, 2025
7 micro habits one woman in early menopause used to lose 50 pounds
Life

7 micro habits one woman in early menopause used to lose 50 pounds

By
February 7, 2025
Two girls, drinking pints of lager, dancing and smiling
Health

6 ways your brain and body benefit when you stop drinking alcohol

By
February 6, 2025
Karsten Munk Knudsen, chief financial officer of Novo Nordisk A/S, at the company's headquarters in Bagsvaerd, Denmark, on Tuesday, Nov. 26, 2024.
Health

As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs

By
February 5, 2025
Novo Nordisk advertising logo on facade building, Danish pharmaceutical healthcare giant Novo Nordisk AS, production innovative drugs, obesity treatment Ozempic, Mainz, Germany June 15, 2024
Health

Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results

By
February 4, 2025
A person stands on a scale.
Health

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

By
February 3, 2025
Ozempic and Wegovy medications side by side
Health

Ozempic and Wegovy surge to national approval with most U.S. adults considering it ‘a good thing’ to treat obesity

By The Associated Press, Kenya Hunter and Linley Sanders
January 31, 2025
The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
Health

Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next

By
January 29, 2025
A person, with only the midsection visible, injects Wegovy under the skin of their stomach.
Finance

Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise

By
January 24, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
Portrait of Crunch Fitness CEO Jim Rowley seated at Fortune's video studio.
Success

The CEO of Crunch Fitness doesn’t think there’s such a thing as work-life balance: ‘That’s for somebody who’s not fully committed’

By Jane Thier and Fortune Editors
January 16, 2025
Radical new proposal from 58 medical experts would decenter BMI from obesity diagnosis
Health

Radical new proposal from 58 medical experts would decenter BMI from obesity diagnosis

By
January 14, 2025
Elon Musk admits he takes an Ozempic-like weight-loss drug that RFK Jr. wants to restrict
Health

Elon Musk admits he takes an Ozempic-like weight-loss drug that RFK Jr. wants to restrict

By
December 27, 2024
Keto vs. paleo diet: which one is better? Experts weigh in
Life

Keto vs. paleo diet: which one is better? Experts weigh in

By
December 20, 2024
Merck snags Chinese obesity drug in nearly $2 billion deal
Tech

Merck snags Chinese obesity drug in nearly $2 billion deal

By Robert Langreth and Bloomberg
December 19, 2024

Most Popular